Quantcast
Last updated on April 25, 2014 at 1:22 EDT

Latest Plymouth Pharmaceuticals Inc. Stories

2006-12-11 15:01:07

TULSA, Okla., Dec. 11 /PRNewswire/ -- Plymouth Pharmaceuticals(R), Inc. announced today that it has launched a new oral prescription medication for the treatment of acne and rosacea. Dermatologist, Dr. Steven A. Smith, MD, FACP, based in Tulsa, Okla. was searching for a better way to treat his acne patients and formulated Acunol(TM) as a result. "Acunol(TM) is a safe biochemical compound with fewer side effects than most prescription acne treatments currently available, and it contains no...